Skip to content

Agrify Corporation RYM Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
Microbot Medical logo
Microbot MedicalMBOT
16.3M
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M
Unusual Machines logo
Unusual MachinesUMAC
0-100%
The Marygold Companies logo
The Marygold CompaniesMGLD
82.5K
KRAKacquisition
 logo
KRAKacquisition KRAQ
0

Other financials

Income statement

See full
Revenue$13.3M+2,370%
Gross profit$10.4M+11,452%
Operating income-$4.0M-9.0%
Net income$19.9M+1,325%
EPS (diluted)$1.33+260%

Balance sheet

See full
Cash & equivalents$33.3M+36.0%
Total debt$89.2M+695%
Total equity$36.6M+36.4%
Total assets$127.5M+180%

Cash flow

See full
Operating cash flow$1.0M+116%
CapEx$2.0K+100%
Free cash flow-$1.8M+15.5%

Valuation

See full
Market cap$54.76M+33.0%
Enterprise value$110.74M+43.3%
P/S1.8×

Profitability

See full
Gross margin68.3%
Operating margin-108.8%
Net margin-39%
FCF margin-244.9%+1,014pp

Returns & leverage

See full
Return on equity-36.9%
Debt / equity2.4×+2.0×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by Agrify Corporation in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.

The official record: Agrify Corporation’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agrify Corporation's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agrify Corporation's warrants and rights outstanding?
Agrify Corporation (RYM) reported warrants and rights outstanding of 11M in Q1 2026.
What is the long-term trend for Agrify Corporation's warrants and rights outstanding?
Over 3 years (2022 to 2025), Agrify Corporation's warrants and rights outstanding has grown at a 261.5% compound annual growth rate (CAGR), from 230.8K to 10.9M.
What does warrants and rights outstanding mean?
This metric quantifies the total number or value of outstanding warrants and rights that grant holders the option to purchase company equity at a specified price. It serves as a key indicator of potential future dilution for existing shareholders upon the exercise of these instruments. Investors track this to assess the impact of derivative securities on the company's capital structure and earnings per share.